Neurology®
The most widely read and highly cited peer-reviewed Neurology journal
Quick Search
Advanced Search
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Koutsis, G.
Right arrow Articles by Vassilopoulos, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koutsis, G.
Right arrow Articles by Vassilopoulos, D.
Related Collections
Right arrow All Neuropsychology/Behavior
Right arrow Multiple sclerosis
Right arrow Risk factors in epidemiology
Right arrowRelated Article
NEUROLOGY 2007;68:546-549
© 2007 American Academy of Neurology

APOE {varepsilon}4 is associated with impaired verbal learning in patients with MS

G. Koutsis, MB, BChir, M. Panas, MD, E. Giogkaraki, MSc, C. Potagas, MD, G. Karadima, PhD, C. Sfagos, MD and D. Vassilopoulos, MD, PhD

From the Department of Neurology, University of Athens, Aeginition Hospital, Greece.

Address correspondence and reprint requests to Dr. G. Koutsis, Department of Neurology, University of Athens, Aeginition Hospital, 74 Vas. Sophias Ave., Athens 11528, Greece; e-mail: gkoutsi2{at}otenet.gr

Objective: To investigate the effect of APOE {varepsilon}4 on different cognitive domains in a population of Greek patients with multiple sclerosis (MS).

Methods: A total of 125 patients with MS and 43 controls were included in this study and underwent neuropsychological assessment with Rao’s Brief Repeatable Battery. All patients with MS were genotyped for APOE. The effect of APOE {varepsilon}4 on different cognitive domains was investigated.

Results: Fifty-one percent of patients with MS were cognitively impaired. E4 carriers had a sixfold increase in the relative risk of impairment in verbal learning vs noncarriers (OR 6.28, 95% CI 1.74 to 22.69). This effect was domain-specific and was not observed in other cognitive domains assessed by the battery.

Conclusion: We found an association of APOE {varepsilon}4 with impaired verbal learning in patients with multiple sclerosis.

Disclosure: The authors report no conflicts of interest.

Received May 31, 2006. Accepted in final form November 7, 2006.


Related Article

February 20 Highlights
Neurology 2007 68: 540-541. [Full Text] [PDF]



This article has been cited by other articles:


Home page
 Mult SclerHome page
E. Portaccio, B. Goretti, V. Zipoli, B. Nacmias, M. L. Stromillo, M. L. Bartolozzi, G. Siracusa, L. Guidi, A. Federico, S. Sorbi, et al.
APOE-{epsilon}4 is not associated with cognitive impairment in relapsing--remitting multiple sclerosis
Multiple Sclerosis, December 1, 2009; 15(12): 1489 - 1494.
[Abstract] [PDF]

Home page
 Mult SclerHome page
L. Julian, L Vella, D Frankel, S. Minden, J. Oksenberg, and D. Mohr
ApoE alleles, depression and positive affect in multiple sclerosis
Multiple Sclerosis, March 1, 2009; 15(3): 311 - 315.
[Abstract] [PDF]

Home page
 Mult SclerHome page
G Koutsis, M Panas, E Giogkaraki, G Karadima, C Sfagos, and D Vassilopoulos
An APOA1 promoter polymorphism is associated with cognitive performance in patients with multiple sclerosis
Multiple Sclerosis, February 1, 2009; 15(2): 174 - 179.
[Abstract] [PDF]

Home page
 Mult SclerHome page
B Duque, J Sepulcre, B Bejarano, L Samaranch, P Pastor, and P Villoslada
Memory decline evolves independently of disease activity in MS
Multiple Sclerosis, August 1, 2008; 14(7): 947 - 953.
[Abstract] [PDF]

Home page
 NeurologyHome page
A. D. Sadovnick and D. H. Jacobs
MS and cognition and APOE: The ongoing conundrum about biomarkers
Neurology, January 15, 2008; 70(3): 164 - 165.
[Full Text] [PDF]